Durable, multi-antigen CAR T responses in B-cell malignancies are in need. The authors here demonstrate that AI-guided CAR designs combined with targeted pathway modulation enhance persistence, prevent antigen escape, and improve anti-tumor efficacy.
- Mohammad Sufyan Ansari
- Varnit Chauhan
- Tanveer Ahmad